期刊文献+

Toll样受体5激动剂CBLB502-Fc融合蛋白的表达纯化及初步鉴定

Expression, Purification and Preliminary Identification of Toll-Like Receptor 5 Agonist CBLB502-Fc Fusion Protein
下载PDF
导出
摘要 目的:构建Toll样受体5激动剂CBLB502-Fc融合蛋白的真核表达载体,并在CHO细胞中表达,纯化得到具有生物学活性的目的蛋白。方法:首先从合成的pUC57-CBLB502质粒中扩增出CBLB502基因片段,酶切后克隆至pUC57-Fc质粒中,然后双酶切pc DNA3.1和pUC57-CBLB502-Fc,将CBLB502-Fc基因片段克隆至载体pc DNA3.1,挑选阳性克隆并测序,再将重组质粒转染CHO细胞,筛选高表达细胞系,用免疫印迹鉴定表达情况,Protein A亲和柱纯化目的蛋白,SDS-PAGE鉴定目的蛋白,用小鼠辐射试验初步验证目的蛋白的生物学活性。结果:构建了pc DNA3.1-CBLB502-Fc真核表达载体;转染CHO细胞,筛选得到CBLB502-Fc高表达细胞系,并经免疫印迹鉴定培养上清;纯化得到较高纯度的融合蛋白并经SDS-PAGE鉴定;小鼠辐射实验表明CBLB502-Fc具有抗辐射作用。结论:真核表达并纯化了具有抗辐射作用CBLB502-Fc融合蛋白,为后续研究CBLB502-Fc的生物学功能奠定了重要基础。 Objective:To obtain CBLB502-Fc fusion protein with biological activity by introducing a designed eukaryotic expression vector into CHO cells.Methods:The CBLB502 gene was amplified from pUC57-CBLB502 plasmid by PCR and cloned into pUC57-Fc vector.Then the CBLB502-Fc was inserted into the pcDNA3.1 vector after double enzyme digestion.The positive clones were picked up and subjected to sequencing.The recombinant plasmid pcDNA3.1-CBLB502-Fc was transfected into CHO cells.Then the highly expressed cell lines were screened.The target protein was purified by Protein A affinity column and identified by SDS-PAGE and Western blotting.The activity of fusion protein was detected by radiation test in mice.Results:The eukaryotic expression vector of pcDNA-CBLB502-Fc was successfully constructed.The cell lines with high expression of CBLB502-Fc fusion protein was screened.The fusion protein was purified by Protein A affinity column and confirmed by Western blotting.The radiation test of mice was made to determine the anti-radiation effect of CBLB502-Fc.Conclusion:We have purified the fusion protein CBLB502-Fc eukaryotic expressed,which layed the important foundation of further study on its biological function.
出处 《生物技术通讯》 CAS 2016年第3期303-307,共5页 Letters in Biotechnology
基金 “重大新药创制”科技重大专项(2012ZX09102-301,2011ZX09301003-001-005)
关键词 TOLL样受体5 CBLB502-Fc 融合蛋白 真核表达 抗辐射 Toll-like receptor 5 CBLB502-Fc fusion protein eukaryotic expression radioprotective
  • 相关文献

参考文献14

  • 1Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity[J]. Nat Immunol, 2001,2(S):675-680.
  • 2Paul C, Faqi A S. Developmental toxicity study of CBLB502 in Wistar rats[J]. Reprod Toxicol, 2014,46(7):12-19.
  • 3Yoon S I, Kurnasov O, Natarajan V, et al. Structural basis of TLR5-flagellin recognition and signaling[J]. Science, 2012,335 (6070):859-864.
  • 4Burdelya L G, Krivokrysenko V I, Tallant T C, et al. An agonist of toll-like receptor 5 has radioproteetive activity in mouse and primate models[J]. Science, 2008,320(5873):226230.
  • 5Kojouharov B M, Brackett C M, Veith J M, et al. Toll-like receptor-5 agonist Entolimod broadens the therapeutic window of 5-fluorouraeil by reducing its toxicity to normal tissues in mice[J]. Oneotarget, 2014,5(3):802.
  • 6Burdelya L G, Brackett C M, Kojouharov B, et al. Central role of liver in antieaneer and radioprotective activities of Toll-like receptor 5 agonist[J]. Proc Natl Acad Sei USA, 2013,110(20):E 1857 -E 1866.
  • 7Burdelya L G, Gleiberman A S, Toshkov I, et al. Toll-like receptor 5 agonist protects mice from dermatitis and oral mucositis caused by local radiation:implications for head-and-neck cancer radiotherapy[J]. Int J Radiation Oncol Biol Phys, 2012, 83(1):228-234.
  • 8Fukuzawa N, Petro M, Baldwin W M, et al. A TLR5 agonist inhibits acute renal ischemic failure[J]. J Immunol, 2011,187 (7):3831-3839.
  • 9Rhee S H, Im E, Pothoulakis C. Toll-like receptor 5 engagement modulates tumor development and growth in a mouse xenograft model of human colon cancer[J]. Gastroenterology, 2008,135(2):518-528.
  • 10Cai Z, Sanchez A, Shi Z, et al. Activation of Toll-like receptor 5 on breast cancer cells by flagellin suppresses cell proliferation and tumor growth[J]. Cancer Res, 2011,71(7):24662475.

二级参考文献8

  • 1Kawai T,Akira S.TLR signaling.Cell Death Differ,2006,13(5):816-825.
  • 2Burdelya LG,Krivokrysenko VI,Tallant TC,ct al.An agonist of toll-like receptor 5 has mdioprotective activity in mouse and primate models.Science,2008,320(5873):226-230.
  • 3Vijay-Kumar M,Aitken JD,Sanders CJ,et al.Flagellin treatment protects against chemicals,bacteria,viruses,and radiation.J Immnnol.2008,180(12):8280-8285.
  • 4Eaves-Pyles T,Murthy K,Liaudet L,ct al.Flagellin,a novel mediator of Salmonella-induced epithelial activation and svstemic inflammation:I kappa B alpha dearadation,induction of nitric oxide synthase,induction of proinflammatory mediators,and cardiovascular dysfunction.J Immunol,2001,166(2):1248-1260.
  • 5Wang Y,Meng A,Lang H,et al.Activation of nuclear factor KB in vivo selectively protects the murine small intestine againat ionizing radiation-induced damage.Cancer Res,2004,64(17):6240-6246.
  • 6Maaser C,Heidamann J,von Eiff C.ct al.Human intestinal microvascular endothelial cells express toll-like receptor 5:a binding partner for bacterial flagellin.J Immunol,2004,172(8):5056-5062.
  • 7Paris F,Fuks z,Kang A,et al.Endothelial apoptosis.as the primary lesion initiating intestinal radiation damage in mice.Science,2001,293(5528):293-297.
  • 8Pasare C,Medzhitov R.Toll-like receptors:linking innate and adaptive immunity.Microbes Infect,2004,6(15):1382-1387.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部